UTHR in the 13F filings
United Therapeutics Corp Del · CUSIP 91307C102
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 Feb 2024
- Managers listing it
- 14
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 11 listed it in both
- Shares listed
- 10,526,421
- combined, among listed positions
- Reported value
- $2.3bn
- combined, at the quarter end
Among the 93 comparable managers: 8 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing UTHR in Q4 2023
14 of 14 holders
Largest increases and reductions, by shares
Increases
- Farallon Capital Management LLCnew position · 476,000 shares now+476,000
- AQR Capital Management LLCexisting position · 551,767 shares now+75,179
- Woodline Partners LPexisting position · 80,277 shares now+69,353
- Schonfeld Strategic Advisors LLCexisting position · 84,595 shares now+35,523
- Caxton Associates LLPexisting position · 30,000 shares now+29,059
Reductions
- Wellington Management Group LLPexisting position · 3,794,010 shares now-327,803
- Fidelity (FMR LLC)existing position · 2,321,040 shares now-283,749
- Renaissance Technologies LLCexisting position · 2,170,214 shares now-80,294
- Acadian Asset Management LLCexisting position · 31,478 shares now-17,768
- PDT Partners LLCexisting position · 9,447 shares now-8,175
New positions and exits
New (3)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 5 | $378m | n.a. | n.a. |
| Q3 2013 | 5 | $587m | n.a. | n.a. |
| Q4 2013 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2014 | 8 | $923m | n.a. | n.a. |
| Q2 2014 | 9 | $716m | n.a. | n.a. |
| Q3 2014 | 11 | $1.1bn | n.a. | n.a. |
| Q4 2014 | 10 | $1.2bn | n.a. | n.a. |
| Q1 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q2 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q3 2015 | 16 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 17 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 12 | $869m | n.a. | n.a. |
| Q3 2016 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2016 | 10 | $1.1bn | n.a. | n.a. |
| Q1 2017 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.2bn | n.a. | n.a. |
| Q3 2017 | 8 | $1.1bn | n.a. | n.a. |
| Q4 2017 | 10 | $1.4bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2018 | 10 | $996m | n.a. | n.a. |
| Q3 2018 | 9 | $1.1bn | n.a. | n.a. |
| Q4 2018 | 9 | $1.0bn | n.a. | n.a. |
| Q1 2019 | 9 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 15 | $804m | n.a. | n.a. |
| Q3 2019 | 17 | $913m | n.a. | n.a. |
| Q4 2019 | 14 | $863m | n.a. | n.a. |
| Q1 2020 | 14 | $1.2bn | n.a. | n.a. |
| Q2 2020 | 14 | $1.4bn | n.a. | n.a. |
| Q3 2020 | 10 | $797m | n.a. | n.a. |
| Q4 2020 | 11 | $1.2bn | n.a. | n.a. |
| Q1 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 16 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 14 | $1.7bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.3bn | n.a. | n.a. |
| Q3 2022 | 17 | $2.2bn | n.a. | n.a. |
| Q4 2022 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2023 | 16 | $2.5bn | n.a. | n.a. |
| Q2 2023 | 12 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 13 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.3bn | 8 | 6 |
| Q1 2024 | 19 | $2.2bn | 14 | 6 |
| Q2 2024 | 14 | $2.5bn | 8 | 7 |
| Q3 2024 | 10 | $2.9bn | 6 | 4 |
| Q4 2024 | 14 | $3.3bn | 8 | 4 |
| Q1 2025 | 14 | $2.1bn | 7 | 6 |
| Q2 2025 | 14 | $1.9bn | 9 | 5 |
| Q3 2025 | 16 | $2.6bn | 8 | 10 |
| Q4 2025 | 14 | $3.8bn | 17 | 20 |
| Q1 2026 | 18 | $5.1bn | 18 | 17 |
| Q2 2026 | 14 | $3.5bn | 19 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own UTHR, latest filings →Back to the 13F Explorer →